Who invested in Moleculent

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 7 months ago

Funding summaryUpdated 26 Oct 2026

$46Mraised across 2 rounds since 2024, from 2 sources

$26MSeries A$20MSeries A

Latest round: Series A, $20MApr 2026
Biggest round: $26MSeries A · Jun 2024
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026

$26MSeries A$20MSeries A

First round: Series A, $26M
Biggest round: $26M
Between rounds: 22 months

The rounds

Apr 2026
Series A$20M1 returning
- ARCH Venture Partners
Source recorded
Jun 2024
Series A$26M1 new
- ARCH Venture Partners
Source recorded

Founders and team

From Moleculent's own website: 2 founders, 5 on the team.

Olle EricssonCEO & Co-founder

Fredrik RoosCTO & Co-founder

Anna Beijar LoeberHead of Program Management
Florian BaumgartnerHead of Product
Sara JupiterHead of Talent
Vasilij GrönrosHead of Operations
Ove ÖhmanBoard member

Everyone who backed them

ARCH Venture PartnersVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Moleculent as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.